Skip to content
Parakho

Epigral Ltd

NSE EPIGRALBSE 543332epigral.com

Q1 FY27, unaudited

Revenue
₹705.36 Cr
Profit after tax
₹99.18 Cr

As filed with the exchange, standalone basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, standalone basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations705.36+16.29%2,527.18
Other income4.10−50.30%14.98
Total income709.46+15.40%2,542.16
Employee benefit expense36.70+22.17%129.66
Finance costs7.22−69.11%71.96
Depreciation & amortisation42.90+3.27%168.29
Total expenses576.28+13.43%2,200.36
Profit before tax133.18+24.78%341.80
Tax expense34.00+163.34%8.79
Profit after tax99.18−38.17%333.01
Total comprehensive income99.19−38.12%333.04
Earnings per share
Earnings per share, basic₹22.99₹77.19
Earnings per share, diluted₹22.99₹77.19

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Q1 FY27 results for every company Parakho holds

Earnings call

Q1 FY27

Epigral reported Q1 FY27 revenue growth of 15% to Rs 709 crore and EBITDA margin of 25%, aided by higher sales volumes and improved realizations despite disruptions from the West Asia conflict affecting shipping and raw material costs. The Board approved capex for two new projects, a 125,000 tonnes per annum Epoxy Resin and Formulations facility and a multipurpose plant for chlorotoluene and epichlorohydrin derivatives, both targeted to have pilot facilities operational by Q2 FY27. Management discussed capacity utilization across segments, ECU and ECH realizations, and the rationale for backward integration and export strategy for the new capacities.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote.

Read the full summary

Earlier calls: Q4 FY26 · All quarters

Filings

12 shown · 56 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Industry

Commodities › Chemicals › Specialty Chemicals

Classification as published by BSE.

Companies also in Specialty Chemicals, in alphabetical order

All 112 companies in Specialty Chemicals

Page generated from filings held to 28 Sept 2026.